COSCIENS Biopharma Inc. (CSCIF) Operating cash flow 2016–2025
COSCIENS Biopharma Inc. (CSCIF) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$8.5MFY2025 · since FY2016: -$29.0M → -$8.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.5M | +41.8% |
| FY2024 | -$14.6M | -464.2% |
| FY2023 | -$2.6M | -149.4% |
| FY2022 | $5.2M | +160.9% |
| FY2021 | -$8.6M | -107.8% |
| FY2020 | -$4.1M | +61.5% |
| FY2019 | -$10.7M | -257.1% |
| FY2018 | $6.8M | +129.8% |
| FY2017 | -$22.9M | +21.0% |
| FY2016 | -$29.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice